Annual Accounts Receivable
$73.07 M
+$47.26 M+183.12%
December 31, 2024
Summary
- As of March 9, 2025, ARQT annual accounts receivable is $73.07 million, with the most recent change of +$47.26 million (+183.12%) on December 31, 2024.
- During the last 3 years, ARQT annual accounts receivable has risen by +$73.07 million (+100.00%).
- ARQT annual accounts receivable is now at all-time high.
Performance
ARQT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$73.07 M
+$12.95 M+21.54%
December 31, 2024
Summary
- As of March 9, 2025, ARQT quarterly accounts receivable is $73.07 million, with the most recent change of +$12.95 million (+21.54%) on December 31, 2024.
- Over the past year, ARQT quarterly accounts receivable has increased by +$47.26 million (+183.12%).
- ARQT quarterly accounts receivable is now at all-time high.
Performance
ARQT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ARQT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +183.1% | +183.1% |
| 3 y3 years | +100.0% | +276.3% |
| 5 y5 years | - | +276.3% |
ARQT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Arcutis Biotherapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $73.07 M(+183.1%) | $73.07 M(+21.5%) |
| Sep 2024 | - | $60.12 M(+38.5%) |
| Jun 2024 | - | $43.41 M(+16.8%) |
| Mar 2024 | - | $37.15 M(+44.0%) |
| Dec 2023 | $25.81 M | $25.81 M(+32.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $19.42 M(+12.8%) |
| Jun 2023 | - | $17.21 M(+34.8%) |
| Mar 2023 | - | $12.77 M(+51.0%) |
| Dec 2022 | $8.46 M(>+9900.0%) | $8.46 M(+247.9%) |
| Sep 2022 | - | $2.43 M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Arcutis Biotherapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual accounts receivable year-on-year change?
- What is Arcutis Biotherapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly accounts receivable year-on-year change?
What is Arcutis Biotherapeutics annual accounts receivable?
The current annual accounts receivable of ARQT is $73.07 M
What is the all time high annual accounts receivable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual accounts receivable is $73.07 M
What is Arcutis Biotherapeutics annual accounts receivable year-on-year change?
Over the past year, ARQT annual accounts receivable has changed by +$47.26 M (+183.12%)
What is Arcutis Biotherapeutics quarterly accounts receivable?
The current quarterly accounts receivable of ARQT is $73.07 M
What is the all time high quarterly accounts receivable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly accounts receivable is $73.07 M
What is Arcutis Biotherapeutics quarterly accounts receivable year-on-year change?
Over the past year, ARQT quarterly accounts receivable has changed by +$47.26 M (+183.12%)